Search Within

CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
Results 1 - 42 of 42
Novel Approaches to Modulate Apoptosis Resistance: Basic and Clinical Implications in the Treatment of Chronic Lymphocytic Leukemia (CLL)

Journal: Current Drug Delivery
Volume: 9,Issue: 1
Page: 30-40
Authors: Aisha Masood, Mohammad A. Shahshahan and Ali R. Jazirehi

Wnt/β-Catenin/LEF-1 Signaling in Chronic Lymphocytic Leukemia (CLL): A Target for Current and Potential Therapeutic Options

Journal: Current Cancer Drug Targets
Volume: 10,Issue: 7
Page: 716-727
Authors: R. K. Gandhirajan, S. J. Poll-Wolbeck, I. Gehrke and K.-A. Kreuzer

Exposure of B Cell Chronic Lymphocytic Leukemia (B-CLL) Cells to Nutlin-3 Induces a Characteristic Gene Expression Profile, which Correlates with Nutlin-3-Mediated Cytotoxicity (Supplementry Table)

Journal: Current Cancer Drug Targets
Volume: 9,Issue: 4
Page: 510-518
Authors: G. Zauli, M. G. di Iasio, P. Secchiero, M. Dal Bo, D. Marconi, R. Bomben, G. Del Poeta and V. Gattei

New and Old Monoclonal Antibodies for the Treatment of Chronic Lymphocytic Leukemia

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 11,Issue: 6
Page: 508-518
Authors: L. Laurenti, L. De Padua, G. D, ’, Arena, B. Vannata, I. Innocenti, M. Tarnani, S. Deaglio, S. Sica, D. G. Efremov and G. Leone

Chronic Lymphocytic Leukemia Therapy: Beyond Chemoimmunotherapy

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 23
Page: 3356-3362
Authors: Julio Delgado, Tycho Baumann, Gabriela Ghita and Emili Montserrat

MicroRNAs as Main Players in the Pathogenesis of Chronic Lymphocytic Leukemia

Journal: MicroRNA
Volume: 2,Issue: 3
Page: 158-164
Authors: Arianna Bottoni and George A. Calin

Deregulation of Apoptosis - Is it Still an Important Issue in Pathogenesis of Chronic Lymphocytic Leukemia?

Journal: Current Cancer Drug Targets
Volume: 16,Issue: 8
Page: 652-658
Authors: Monika Podhorecka, Arkadiusz Macheta, Maria Bozko, Andrzej Bozko, Nisar P. Malek and Przemyslaw Bozko

Cell Penetrating Peptides as a Therapeutic Strategy in Chronic Lymphocytic Leukemia

Journal: Protein & Peptide Letters
Volume: 22,Issue: 6
Page: 539-546
Authors: Issam Arrouss, Didier Decaudin, Sylvain Choquet, Nabih Azar, Christophe Parizot, Jean M. Zini, Fariba Nemati and Angelita Rebollo

MicroRNAs in Chronic Lymphocytic Leukemia: An Old Disease with New Genetic Insights

Journal: MicroRNA
Volume: 5,Issue: 2
Page: 106-112
Authors: Maria Ciccone and George A. Calin

Novel Drugs for Chronic Lymphoid Leukemias: Mechanism of Action and Therapeutic Activity

Journal: Current Medicinal Chemistry
Volume: 16,Issue: 18
Page: 2212-2234
Authors: Tadeusz Robak

Recombinant Immunotoxins for the Treatment of Chemoresistant Hematologic Malignancies

Journal: Current Pharmaceutical Design
Volume: 15,Issue: 23
Page: 2652-2664
Authors: Robert J. Kreitman

Synthesis and Biological Activity of New Class of Dioxygenated Anticancer Agents

Journal: Current Medicinal Chemistry-Anti-Cancer Agents
Volume: 5,Issue: 3
Page: 215-237
Authors: Maria Dolors Pujol, Manel Romero and Isabel Sanchez

Microenvironmental Interactions in Chronic Lymphocytic Leukemia: Hints for Pathogenesis and Identification of Targets for Rational Therapy

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 23
Page: 3323-3334
Authors: Michele Dal Bo, Riccardo Bomben, Antonella Zucchetto, Giovanni Del Poeta, Gianluca Gaidano, Silvia Deaglio, Dimitar G. Efremov and Valter Gattei

Immune Dysfunction in Chronic Lymphocytic Leukemia: The Role for Immunotherapy

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 23
Page: 3389-3398
Authors: John C. Riches, Alan G. Ramsay and John G. Gribben

Targeting Bcl-2 in CLL

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 30
Page: 5109-5115
Authors: M. Rogalinska and Z.M. Kilianska

Ibrutinib: A New Frontier in the Treatment of Chronic Lymphocytic Leukemia by Bruton’s Tyrosine Kinase Inhibition

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 11,Issue: 4
Page: 265-271
Authors: Ajoy Lawrence Dias and Dharamvir Jain

Targeting Signaling Pathways in Chronic Lymphocytic Leukemia

Journal: Current Cancer Drug Targets
Volume: 16,Issue: 8
Page: 669-688
Authors: Alice F. Muggen, Simar P. Singh, Rudi W. Hendriks and Anton W. Langerak

Mechanistic and Clinical Aspects of Lenalidomide Treatment for Chronic Lymphocytic Leukemia

Journal: Current Cancer Drug Targets
Volume: 16,Issue: 8
Page: 689-700
Authors: John C. Riches and John G. Gribben

Refractory Chronic Lymphocytic Leukemia: A Therapeutic Challenge

Journal: Current Cancer Drug Targets
Volume: 16,Issue: 8
Page: 701-709
Authors: Lukas Smolej

Exploratory Study on the Effects of Biodegradable Nanoparticles with Drugs on Malignant B Cells and on a Human/Mouse Model of Burkitt Lymphoma

Journal: Current Clinical Pharmacology
Volume: 5,Issue: 4
Page: 246-250
Authors: Gustavo H. Marin, Eduardo Mansilla, Nelly Mezzaroba, Sonia Zorzet, Luis Nunez, Gustavo Larsen, Jose M. Tau, Alberto Maceira, Ruben Spretz, Carol Mertz, Sabrina Ingrao, Claudio Tripodo, Francesco Tedesco and Paolo Macor

Amplicons as Vaccine Vectors

Journal: Current Gene Therapy
Volume: 6,Issue: 3
Page: 383-392
Authors: Kathlyn Santos, Cindy M.P. Duke and Stephen Dewhurst

Molecular Pathogenesis of Chronic Lymphocytic Leukemia

Journal: Current Molecular Medicine
Volume: 6,Issue: 6
Page: 665-675
Authors: Alexey V. Danilov, Olga V. Danilova, Andreas K. Klein and Brigitte T. Huber

Genetics, Gene Expression, and Targeted Therapies in Chronic Lymphocytic Leukemia

Journal: Current Drug Targets
Volume: 7,Issue: 10
Page: 1313-1327
Authors: Dirk Winkler, Hartmut Dohner and Stephan Stilgenbauer

Potential New Agents for Chronic Lymphocytic Leukemia Treatment

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 10,Issue: 9
Page: 666-682
Authors: Malgorzata Rogalinska and Zofia M. Kilianska


The Role of B Cell Receptor Stimulation in CLL Pathogenesis

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 23
Page: 3335-3355
Authors: Laurens P. Kil, Saravanan Yuvaraj, Anton W. Langerak and Rudi W. Hendriks

Novel Insights in Molecular Mechanisms of CLL

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 23
Page: 3363-3372
Authors: Nicola Zanesi, Veronica Balatti, Arianna Bottoni, Carlo M. Croce and Yuri Pekarsky

Therapy of Elderly/Comorbid Patients with Chronic Lymphocytic Leukemia

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 23
Page: 3399-3405
Authors: Lukas Smolej

Removal of the Tag from His-tagged ILYd4, a Human CD59 Inhibitor, Significantly Improves its Physical Properties and its Activity

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 27
Page: 4187-4196
Authors: Lin Wu, Sanbao Su, Fengming Liu, Tao Xu, Xiaoxiao Wang, Yan Huang, Xinlu Sun, Xiaowen Ge, Ting Chen, Huixia Liu, Chun Wang, Michael Chorev, Ting Xu and Xuebin Qin

A Targeted Therapy for Protein and Lipid Kinases in Chronic Lymphocytic Leukemia

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 31
Page: 5294-5318
Authors: P. Robak and T. Robak

Ofatumumab: A Novel Anti-CD20 Monoclonal Antibody for the Treatment of Chronic Lymphocytic Leukemia

Journal: Current Drug Therapy
Volume: 7,Issue: 4
Page: 281-289
Authors: Ravindra R. Chuda, Prakash Vishnu and David Aboulafia

Alternative Splicing in Chronic Myeloid Leukemia (CML): A Novel Therapeutic Target?

Journal: Current Cancer Drug Targets
Volume: 13,Issue: 7
Page: 735-748
Authors: Sophia Adamia, Patrick M. Pilarski, Michal Bar-Natan, Richard M. Stone and James D. Griffin

Origins and Consequences of AID Expression in Lymphoid Neoplasms

Journal: Current Immunology Reviews
Volume: 9,Issue: 2
Page: 72-85
Authors: Damien Montamat-Sicotte, Florencia Palacios, Javier M. Di Noia and Pablo Oppezzo

Multiple Metamorphoses of CD38 from Prognostic Marker to Disease Modifier to Therapeutic Target in Chronic Lymphocytic Leukemia

Journal: Current Topics in Medicinal Chemistry
Volume: 13,Issue: 23
Page: 2955-2964
Authors: Tiziana Vaisitti, Valentina Audrito, Sara Serra, Cinzia Bologna, Francesca Arruga, Davide Brusa, Roberta Buonincontri, Branimir Gizdic and Silvia Deaglio

New Therapies for Chronic Lymphocytic Leukemia

Journal: Current Cancer Therapy Reviews
Volume: 9,Issue: 4
Page: 245-257
Authors: Pawel Robak and Tadeusz Robak

AKT-pathway Inhibition in Chronic Lymphocytic Leukemia Reveals Response Relationships Defined by TCL1

Journal: Current Cancer Drug Targets
Volume: 14,Issue: 8
Page: 700-712
Authors: Alexandra Schrader, Wagma Popal, Nils Lilienthal, Giuliano Crispatzu, Petra Mayer, Dan Jones, Michael Hallek and Marco Herling

Functional and Clinical Significance of the Integrin Alpha Chain CD49d Expression in Chronic Lymphocytic Leukemia

Journal: Current Cancer Drug Targets
Volume: 16,Issue: 8
Page: 659-668
Authors: Michele Dal Bo, Erika Tissino, Dania Benedetti, Chiara Caldana, Riccardo Bomben, Giovanni Del Poeta, Gianluca Gaidano, Francesca Maria Rossi, Pietro Bulian, Antonella Zucchetto and Valter Gattei

Therapeutic Approach to Patients with Chronic Lymphocytic Leukemia and Significant Comorbid Conditions

Journal: Current Cancer Drug Targets
Volume: 16,Issue: 8
Page: 710-720
Authors: Lukas Smolej

Survival and Immunosuppression Induced by Hepatocyte Growth Factor in Chronic Lymphocytic Leukemia

Journal: Current Molecular Medicine
Volume: 17,Issue: 1
Page: 24-33
Authors: P. Giannoni, G. Cutrona and D. de Totero*

CD20-based Immunotherapy of B-cell Derived Hematologic Malignancies

Journal: Current Cancer Drug Targets
Volume: 17,Issue: 5
Page: 423-444
Authors: Dariush Shanehbandi, Jafar Majidi*, Tohid Kazemi*, Behzad Baradaran and Leili Aghebati-Maleki

Novel Monoclonal Antibodies for the Treatment of Chronic Lymphocytic Leukemia

Journal: Current Cancer Drug Targets
Volume: 8,Issue: 2
Page: 156-171
Authors: Tadeusz Robak

Chrysin Induces Apoptosis in Peripheral Blood Lymphocytes Isolated from Human Chronic Lymphocytic Leukemia

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15,Issue: 2
Page: 189-195
Authors: Milan Zaric, Marina Mitrovic, Ivana Nikolic, Dejan Baskic, Suzana Popovic, Predrag Djurdjevic, Zoran Milosavljevic and Ivanka Zelen

Results 1 - 42 of 42